Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions

The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes - "Mechanisms and Models of Drug Interactions" and "Antimicrobial Drug Interactions". This volume, "Antimicrobial Drug Interactions," delivers a quick clinical resource...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Pai, Manjunath P. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Kiser, Jennifer J. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Gubbins, Paul O. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Rodvold, Keith A. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Humana, 2018.
Έκδοση:4th ed. 2018.
Σειρά:Infectious Disease
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04157nam a2200553 4500
001 978-3-319-72416-4
003 DE-He213
005 20191025032517.0
007 cr nn 008mamaa
008 180319s2018 gw | s |||| 0|eng d
020 |a 9783319724164  |9 978-3-319-72416-4 
024 7 |a 10.1007/978-3-319-72416-4  |2 doi 
040 |d GrThAP 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a TDC  |2 thema 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions  |h [electronic resource] /  |c edited by Manjunath P. Pai, Jennifer J. Kiser, Paul O. Gubbins, Keith A. Rodvold. 
250 |a 4th ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Humana,  |c 2018. 
300 |a XVI, 565 p. 2 illus., 1 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Infectious Disease 
505 0 |a Beta-Lactam Antibiotics -- Macrolides, Azalides, and Ketolides -- Quinolones -- Glycopeptides, Lipopeptides, and Lipoglycopeptides -- Miscellaneous Antibiotics -- Drugs for Tuberculosis -- Drug Interactions in HIV: Protease and Integrase Inhibitors -- Drug Interactions in HIV: Nucleoside, Nucleotide, and Nonnucleoside Reverse Transcriptase Inhibitors and Entry Inhibitors -- Hepatitis B and Hepatitis C Antiviral Agents -- Drug Interactions of Non-HIV Antiviral Agents -- Antifungal Agents -- Antimalarial Agents -- Antiprotozoal and Anthelminthic Agents. 
520 |a The 4th edition of Drug Interactions in Infectious Diseases is being split into two separate volumes - "Mechanisms and Models of Drug Interactions" and "Antimicrobial Drug Interactions". This volume, "Antimicrobial Drug Interactions," delivers a quick clinical resource that distills relevant drug interactions by antimicrobial drug class. The book provides informative tables on specific drug-drug interactions that include the degree and severity of the expected interaction. A mechanistic basis for drug-drug interactions is also provided to link observed interactions to pharmacologic characteristics of key drug classes. This complete resource is organized by major antibacterial, antimycobacterial, antiviral, antifungal, antimalarial, and antiprotozoal class. In line with current innovations in antimicrobial drug development, a distinct chapter on the pharmacologic management of drug interactions in hepatitis B virus (HBV) and hepatitis C virus (HCV)-related infections is included. Two new chapters are dedicated to the management of human immunodeficiency virus (HIV) drug-drug interactions given the breadth of antiretroviral class-specific effects. This comprehensive review of known drug interactions and strategies to manage them is an invaluable resource to all health care practitioners. 
650 0 |a Pharmaceutical technology. 
650 0 |a Infectious diseases. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmaceutical Sciences/Technology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21010 
650 2 4 |a Infectious Diseases.  |0 http://scigraph.springernature.com/things/product-market-codes/H33096 
650 2 4 |a Pharmacy.  |0 http://scigraph.springernature.com/things/product-market-codes/F00008 
700 1 |a Pai, Manjunath P.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Kiser, Jennifer J.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Gubbins, Paul O.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Rodvold, Keith A.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319724157 
776 0 8 |i Printed edition:  |z 9783319724171 
776 0 8 |i Printed edition:  |z 9783030101978 
830 0 |a Infectious Disease 
856 4 0 |u https://doi.org/10.1007/978-3-319-72416-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)